BIND Biosciences Secures $1,400,000 Series C Financing

  • Feed Type
  • Date
    6/29/2010
  • Company Name
    BIND Biosciences
  • Mailing Address
    64 Sidney Street Cambridge, MA 02139
  • Company Description
    BIND Biosciences, Inc. is a venture backed biopharmaceutical company focused on engineering targeted therapeutics. BIND’s technology was developed by world class laboratories at MIT and Harvard.
  • Website
    http://www.bindbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,400,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The company plans to use some of the new funding to usher its first drug-loaded nanoparticle into a Phase I clinical study for treating solid tumors.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.